RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Ehlers-Danlos Syndrome: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
The significance of hypermobility syndromes for rheumatology
Jürgen Braun, Exploration of Musculoskeletal Diseases (18 October 2026)
https://doi.org/10.37349/emd.2026.1007139
- 2.
ASPECTOS ORTOPÉDICOS DA SÍNDROME DE EHLERS-DANLOS EM ADULTOS
Pedro Henrique Santos Silva, Revista Brasileira de Saúde (15 October 2026)
https://doi.org/10.22533/at.ed.82082182614106
- 3.
How can occupational therapy be tailored to address the unique needs of neurodivergent individuals with Ehlers-Danlos Syndrome and chronic pain?
Tripdatabase, Zenodo (CERN European Organization for Nuclear Research) (15 October 2026)
https://doi.org/10.5281/zenodo.23393162
- 4.
Relational Kinetic Chains: A Patient Guide to Self-Directed Stability-Muscle Activation in Hypermobile EDS
Ashley Nicole Wilder et al., Zenodo (CERN European Organization for Nuclear Research) (15 October 2026)
https://doi.org/10.5281/zenodo.23402057
- 5.
Recurrent helical COL1A1 E678K variant in three families with an EDS-predominant phenotype expanding the clinical and molecular spectrum of COL1-related overlap disorder
Shaimaa Helal et al., Journal of Medical Genetics (12 October 2026)
https://doi.org/10.1136/jmg-2026-111532
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Ehlers-Danlos Syndrome
Ehlers-Danlos syndrome is a group of genetic conditions affecting connective tissue. It causes joints to be unusually flexible and skin to be more stretchy or fragile. Symptoms vary widely. There is no cure, but treatments help manage pain and prevent injury.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Joint hypermobility (JHM) arises from multifactorial influences including age, gender, trauma, conditioning, infection, inflammation, and genetic factors. It frequently co-occurs with skin overstretching seen in connective tissue disorders such as Ehlers-Danlos syndrome (EDS). The 2017 international classification updated definitions to distinguish primarily between hypermobile EDS (hEDS) and generalized hypermobility spectrum disorder (g-HSD). Primary diagnostic tools remain the Beighton score and a validated 5-part questionnaire (5PQ) instrument. As in the general population, hypermobility is observed frequently with inflammatory rheumatic musculoskeletal diseases (RMD) and in patients presenting with arthralgia without overt inflammation. However, the extent to which hypermobility influences the clinical course or treatment outcomes remains unclear and warrants further research.
Common Questions
What is Ehlers-Danlos Syndrome?
Ehlers-Danlos syndrome is a group of genetic conditions affecting connective tissue. It causes joints to be unusually flexible and skin to be more stretchy or fragile. Symptoms vary widely. There is no cure, but treatments help manage pain and prevent injury.
How many clinical trials are available for Ehlers-Danlos Syndrome?
RareWays currently indexes 45 clinical trials for Ehlers-Danlos Syndrome, of which 6 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Ehlers-Danlos Syndrome come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Ehlers-Danlos Syndrome.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.